User menu

Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.

Bibliographic reference Stefanou, Dimitra T ; Episkopou, Charikleia ; Kyrtopoulos, Soterios A ; Bamias, Aristotelis ; Gkotzamanidou, Maria ; et. al. Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.. In: British Journal of Clinical Pharmacology, Vol. 74, no. 5, p. 842-853 (2012)
Permanent URL
  1. Fichtinger-Schepman, Cancer Res, 50, 7887 (1990)
  2. Parker Ricardo J., Gill Indrani, Tarone Robert, Vionnet Justine A., Grunberg Steven, Muggia Franco M., Reed Eddie, Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry, 10.1093/carcin/12.7.1253
  3. Dimopoulos Meletios A., Souliotis Vassilis L., Anagnostopoulos Athanasios, Papadimitriou Christos, Sfikakis Petros P., Extent of Damage and Repair in thep53Tumor-Suppressor Gene After Treatment of Myeloma Patients With High-Dose Melphalan and Autologous Blood Stem-Cell Transplantation Is Individualized and May Predict Clinical Outcome, 10.1200/jco.2005.07.385
  4. Reed E., Ozols R. F., Tarone R., Yuspa S. H., Poirier M. C., Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy., 10.1073/pnas.84.14.5024
  5. Reed, Cancer Res, 50, 2256 (1990)
  6. Dimopoulos M. A., Souliotis V. L., Anagnostopoulos A., Bamia C., Pouli A., Baltadakis I., Terpos E., Kyrtopoulos S. A., Sfikakis P. P., Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma, 10.3324/haematol.11435
  7. Fisch, Clin Cancer Res, 2, 1063 (1996)
  8. Souliotis, Clin Cancer Res, 9, 4465 (2003)
  9. Chaney Stephen G., Sancar Aziz, DNA Repair: Enzymatic Mechanisms and Relevance to Drug Response, 10.1093/jnci/88.19.1346
  10. Barlogie Bart, Kyle Robert A., Anderson Kenneth C., Greipp Philip R., Lazarus Hillard M., Hurd David D., McCoy Jason, Moore Dennis F., Dakhil Shaker R., Lanier Keith S., Chapman Robert A., Cromer Jeana N., Salmon Sydney E., Durie Brian, Crowley John C., Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321, 10.1200/jco.2005.04.5807
  11. Child J. Anthony, Morgan Gareth J., Davies Faith E., Owen Roger G., Bell Susan E., Hawkins Kim, Brown Julia, Drayson Mark T., Selby Peter J., High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma, 10.1056/nejmoa022340
  12. Edler Michael, Jakubowski Norbert, Linscheid Michael, Quantitative determination of melphalan DNA adducts using HPLC—inductively coupled mass spectrometry, 10.1002/jms.1009
  13. Balcome Shawn, Park Soobong, Quirk Dorr Danaè R., Hafner Lucy, Phillips Laura, Tretyakova Natalia, Adenine-Containing DNA−DNA Cross-Links of Antitumor Nitrogen Mustards, 10.1021/tx0499463
  14. Hansson, Cancer Res, 47, 2631 (1987)
  15. Desoize Bernard, Madoulet Claudie, Particular aspects of platinum compounds used at present in cancer treatment, 10.1016/s1040-8428(01)00219-0
  16. Wang Dong, Lippard Stephen J., Cellular processing of platinum anticancer drugs, 10.1038/nrd1691
  17. Episkopou Hara, Kyrtopoulos Soterios A., Sfikakis Petros P., Dimopoulos Meletios A., Souliotis Vassilis L., The repair of melphalan-induced DNA adducts in the transcribed strand of active genes is subject to a strong polarity effect, 10.1016/j.mrfmmm.2011.06.012
  18. Grimaldi Keith A, McGurk Claire J, McHugh Peter J, Hartley John A, PCR-Based Methods for Detecting DNA Damage and its Repair at the Sub-gene and Single Nucleotide Levels in Cells, 10.1385/mb:20:2:181
  19. Van Houten Bennett, Cheng Suzanne, Chen Yiming, Measuring gene-specific nucleotide excision repair in human cells using quantitative amplification of long targets from nanogram quantities of DNA, 10.1016/s0921-8777(00)00018-5
  20. Jennerwein M.M., Eastman A., A polymerase chain reaction-based method to detect cisplatin adducts in specific genes, 10.1093/nar/19.22.6209
  21. Kalinowski Douglas P., Illenye Sharon, Van Houten Ben, Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay, 10.1093/nar/20.13.3485
  22. Grimaldi K.A., Bingham J.P., Souhami R.L., Hartley J.A., DNA Damage by Anticancer Agents and Its Repair: Mapping in Cells at the Subgene Level with Quantitative Polymerase Chain Reaction, 10.1006/abio.1994.1479
  23. Yakes F. M., Van Houten B., Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress, 10.1073/pnas.94.2.514
  24. Chen Xin-Ming, Cullinane Carleen, Gray Peter J, Phillips Don R, DNA damage by nitrogen mustard in a gene containing multiple Sp1-binding sites, 10.1016/s1383-5718(99)00114-x
  25. BladÉ Joan, Samson Diana, Reece Donna, Apperley Jane, BJÖrkstrand Bo, Gahrton GÖsta, Gertz Morie, Giralt Sergio, Jagannath SUNDARr, Vesole David, , CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH-DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION : Annotation, 10.1046/j.1365-2141.1998.00930.x
  26. Frgala T., Kalous O., Proffitt R. T., Reynolds C. P., A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations, 10.1158/1535-7163.mct-04-0331
  27. Sfikakis Peter P., Souliotis Vassillis L., Akbar Arnie N., Katsilambros Nikos, Hoffbrand Victor A., Panayiotidis Panayiotis, Regulation of bcl-2 and fas expression in primary activation of human peripheral lymphocytes is not sensitive to dexamethasone or cyclosporin-A, 10.1016/0198-8859(96)00136-x
  28. Thomas D. C., Morton A. G., Bohr V. A., Sancar A., General method for quantifying base adducts in specific mammalian genes., 10.1073/pnas.85.11.3723
  29. Wang Yu-Chieh, Lee Pei-Jung, Shih Chuen-Ming, Chen Hsing-Yu, Lee Chin-Chu, Chang Yuan-Yen, Hsu Yu-Ting, Liang Ying-Ju, Wang Li-Ya, Han Wen-Hua, Wang Yi-Ching, Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction, 10.1016/s0003-2697(03)00330-0
  30. Oshita, Oncol Res, 5, 111 (1993)
  31. Tilby Michael J., McCartney Hazel, Gould Katherine A., O'Hare C. Caroline, Hartley John A., Hall Andrew G., Golding Bernard T., Lawley Philip D., A Monofunctional Derivative of Melphalan:  Preparation, DNA Alkylation Products, and Determination of the Specificity of Monoclonal Antibodies That Recognize Melphalan−DNA Adducts, 10.1021/tx980129a
  32. HUSAIN K, WHITWORTH C, RYBAK L, Time response of carboplatin-induced nephrotoxicity in rats, 10.1016/j.phrs.2004.04.001
  33. Bingham J. P., Hartley J. A., Souhami R. L., Grimaldi K. A., Strand-Specific Measurement of Cisplatin-Induced DNA Damage and Repair Using Quantitative PCR, 10.1093/nar/24.5.987
  34. Reece PhillipA., Hill HeatherS., Green R.Malcolm, Morris RaymondG., Dale BarryM., Kotasek Dusan, Sage RobertE., Renal clearance and protein binding of melphalan in patients with cancer, 10.1007/bf00254244